Skip to Content

Thermo Fisher Scientific Inc TMO Stock Quote

| Rating as of


Morningstar‘s Stock Analysis TMO

Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


Capital Allocation


Thermo Fisher's Core Business Strengths Offset Decline in COVID-19 Testing

Alex Morozov, CFA Regional Director

Business Strategy and Outlook

| Alex Morozov, CFA |

Thermo Fisher didn’t just come out of the toughest two years for the global economy unscathed, the company managed to deliver its best year ever despite challenges around the economy and spending budgets. Being the premier life science supplier and having an unmatched portfolio of products, resources, and manufacturing capabilities have allowed the firm to be among the first to market with a reliable coronavirus test and at capacity needed to meet massive demand. The coronavirus pandemic reaffirmed the company's entrenched and dominant positioning with the supply chain.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics TMO

Company Profile TMO

Business Description

Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2022 (revenue figures include some cross-segment revenue): analytical technologies (15% of sales); specialty diagnostic products (10%); life science solutions (30%); and lab products and services, which includes CRO services (51%).

168 Third Avenue
Waltham, MA, 02451
T +1 781 622-1000
Industry Diagnostics & Research
Most Recent Earnings Sep 30, 2022
Fiscal Year End Dec 31, 2022
Employees 130,000

Related News TMO